share_log

Arcutis Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Matsuda Masaru

SEC ·  Dec 3 13:22

Summary by Moomoo AI

Matsuda Masaru, associated with Arcutis Biotherapeutics, completed a series of stock purchases. On 05/31/2024, he acquired 4,000 shares of Common Stock at $1.692 per share. This transaction was followed by another purchase on 11/30/2024, where he bought 1,657 shares at $7.106 per share.The total number of shares acquired by Matsuda Masaru during this period was 5,657, with the transaction prices ranging from $1.692 to $7.106. Following these transactions, he now holds a total of 187,030 shares directly. The transactions were completed as open market or private purchases, indicating a strategic increase in his holdings in Arcutis Biotherapeutics.
Matsuda Masaru, associated with Arcutis Biotherapeutics, completed a series of stock purchases. On 05/31/2024, he acquired 4,000 shares of Common Stock at $1.692 per share. This transaction was followed by another purchase on 11/30/2024, where he bought 1,657 shares at $7.106 per share.The total number of shares acquired by Matsuda Masaru during this period was 5,657, with the transaction prices ranging from $1.692 to $7.106. Following these transactions, he now holds a total of 187,030 shares directly. The transactions were completed as open market or private purchases, indicating a strategic increase in his holdings in Arcutis Biotherapeutics.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more